Organization and Personnel Changes

February 26,2021
J-Pharma Co., Ltd.

PDF For Print

Yokohama, Japan, February 26, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes upon the approval of extraordinary meeting of shareholders on February 25, 2020.

1.Transition to a company with board of company auditors

2.Changes of Board Members

① New Board Members

Title Name Current Position
External Director Sadashi Suzuki Representative, Newton Biocapital Partners, Japan
External Director Shinichiro Komoto Partner, Eight-Roads Ventures Japan

② New Auditors

Title Name Current Position
Audit & Supervisory
Board Member
Tadashi Takeuchi Small and Medium Enterprise Management Consultant
Audit & Supervisory
Board Member
Teruhisa Tajima Certified Public Accountant
Representative, Tajima CPA firm
Audit & Supervisory
Board Member
Toshio Furuta Lawyer
Representative, Clair Law firm

③ Retired Audit & Supervisory Board Member

Name
Yukou Ikuta
Futoshi Nakamura

【Reference】
All the Board Members as of February 26

Title Name Current Position
Chief Executive Officer Masuhiro Yoshitake
Director, Corporate Planning Yoshinori Bamba
Director, R&D Takehiro Igawa
External Director Satoe Otsubo Director, Venture Investment Team

Shinsei Corporate Investment

External Director Sadashi Suzuki Representative, Newton Biocapital Partners, Japan
External Director Shinichiro Komoto Eight-Roads Ventures Japan
External Director Toshiyuki Mori Representative, TM Partners
Audit & Supervisory Board Member Tadashi Takeuchi Small and Medium Enterprise Management Consultant
Audit & Supervisory Board Member Teruhisa Tajima Certified Public Accountant
Representative, Tajima CPA firm
Audit & Supervisory Board Member Toshio Furuta Lawyer
Representative, Clair Law firm

Contact: Tomohiro Yuzawa, Director,
Corporate Management Dept.
Tel: 045-506-1155
info@j-pharma.com